---
document_datetime: 2023-09-21 19:35:46
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/silgard-epar-all-authorised-presentations_en.pdf
document_name: silgard-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.5843713
conversion_datetime: 2025-12-22 10:32:00.819166
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
EU Number

EU/1/06/358/001

EU/1/06/358/002

EU/1/06/358/003

EU/1/06/358/004

EU/1/06/358/005

EU/1/06/358/006

EU/1/06/358/007

EU/1/06/358/008

EU/1/06/358/018

EU/1/06/358/019

EU/1/06/358/020

EU/1/06/358/021

Invented name

Silgard

Silgard

Silgard

Silgard

Silgard

Silgard

Silgard

Silgard

Silgard

Silgard

Silgard

Strength

1

--

1

--

1

--

1

--

1

--

1

--

1

--

--

1

1

--

1

--

1

--

Silgard

1

--

1

1 dose (0.5 ml) contains approximately:

20 micrograms

Human Papillomavirus a  Type 6 L1 protein b,c

Human Papillomavirus a  Type 11 L1 protein b,c      40 micrograms

Human Papillomavirus a  Type 16 L1 protein b,c      40 micrograms

Human Papillomavirus a  Type 18 L1 protein b,c      20 micrograms

a  Human Papillomavirus = HPV

Pharmaceutical

Form

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Suspension for injection

Route of

Administration

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Intramuscular use

Packaging vial (glass)

vial (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

vial (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

pre-filled syringe (glass)

Content

(concentration)

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

0.5 ml

Package size

1 vial

10 vials

1 pre-filled syringe

10 pre-filled syringes

1 pre-filled syringe + 1

needle

10 pre-filled syringes +

10 needles

1 pre-filled syringe + 2

needles

10 pre-filled syringes +

20 needles

20 vials

20 pre-filled syringes

20 pre-filled syringes +

20 needles

20 pre-filled syringe + 40

needles

1/2 Medicinal product no longer authorised b  L1 protein in the form of virus-like particles produced in yeast cells (Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA technology c  adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (225 micrograms Al)

<div style=\"page-break-after: always\"></div>

2/2 Medicinal product no longer authorised